Stu Heilsberg

About Stu Heilsberg

I’ve run product lines, sat in the C-suite, and made the commercialization decisions that determine whether precision medicine and digital health companies actually grow. That’s the experience I bring to Notenda. I started at MIT (engineering), then Motorola and Qualcomm — learning how to launch validated products at scale. At Qualcomm I built and launched new businesses in wireless health and mobile commerce, each projected to exceed $500M, and filed 5 patents. At Intuit I ran the $450M TurboTax business (20M+ users). At WuXi NextCODE and Syapse I took that operating experience directly into the genomics and digital health world — running products, commercial strategy, and market positioning. In 2018 I co-founded Notenda with a specific thesis: the answers to commercial failure in precision medicine and digital health almost always live outside the building, with buyers, payers, and clinicians who will tell you exactly what’s wrong — if you ask the right questions in the right way. Over the years, our team has conducted more than 1,900 exploratory interviews — representing over 1,300 hours of structured conversations with clinicians, scientists, patients, payers, and consumers. The behavioral patterns and validated insights from that body of research inform every recommendation we make. Every engagement also adds new stakeholder interviews specific to your context. We shape and validate every insight before it becomes a recommendation. Selected outcomes from recent engagements: · 50+ distribution partners at global genomics platform launch (5 months) · 40% reduction in time-to-close for a life sciences analytics firm · 2× sales growth identified on a $1B+ oncology diagnostics portfolio (273 interviews, 13 projects, 11 months) I’ve also written about what I’ve learned: The Answers Are Outside The Building captures my market validation methodology. I co-authored a peer-reviewed paper on translating genomics into clinical practice. If you’re building in precision medicine or digital health and want a partner who has operated at every scale — I’d like to talk.

Experience

1. Managing Partner

   Notenda

   Jun 2018 — Present · San Diego, CA, US

   Notenda is the commercial strategy consultancy I co-founded in 2018 to deliver C-suite-level commercialization expertise to precision medicine and digital health companies. We work at three inflection points: Define (validate what the market needs before you build), Launch (drive adoption from day one), and Grow (remove barriers and accelerate). Over the years our team has conducted more than 1,900 exploratory interviews — over 1,300 hours of structured research — and every engagement adds new interviews specific to your context. We shape and validate every insight before it becomes a recommendation. Clients have included Illumina, Geisinger Health, Genomics England, AltheaDx, Helix, Exact Sciences, and others. Selected outcomes: · 50+ distribution partners at global launch (genomics platform) · 40% reduction in time-to-close (life sciences analytics) · 2× sales growth identified on a $1B+ portfolio (oncology diagnostics)

Education

• Northwestern University - Kellogg School of Management

  MBA, Marketing, Product Management, & Operations Management

  1997

• Massachusetts Institute of Technology

  B.S., Mechanical Engineering

  1991

Skills

• Strategic Partnerships
• Product Management
• Start-Ups
• Mobile Devices
• New Business Development
• Mobile Applications
• Business Development
• Strategy
• Strategic Planning
• Product Marketing